CpG island hypermethylation-associated silencing of small nucleolar RNAs in human cancer

RNA Biology

Volumn 9, Issue 6, 2012, Pages 881-890

  Ferreira, Humberto J ^a,b   Heyn, Holger ^a   Moutinho, Cátia ^a   Esteller, Manel ^a,c,d  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

DNA methylation; Epigenetics; Non coding RNA; Small nucleolar RNAs

Indexed keywords

PROTEIN; SEMAPHORIN; SEMAPHORIN 5A; SMALL NUCLEAR RNA; SOLUTE CARRIER FAMILY 47 MEMBER 1 PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LEUKEMIA; RNA PROCESSING;

EID: 84863446610     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.19353     Document Type: Article

References (56)

1. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004; 431:931-45; PMID:15496913; http://dx.doi.org/10.1038/nature03001.
2. Mattick JS. Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms. Bioessays 2003; 25:930-9; PMID:14505360; http://dx.doi.org/10.1002/bies.10332.
3. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12:861-74; PMID:22094949; http://dx.doi.org/10.1038/nrg3074.
4. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5:522-31; PMID:15211354; http://dx.doi.org/10. 1038/nrg1379.
5. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-66; PMID:17060945; http://dx.doi.org/10.1038/nrc1997.
6. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-69; PMID:16557279; http://dx.doi.org/10.1038/ nrc1840.
7. Hammond SM. MicroRNAs as tumor suppressors. Nat Genet 2007; 39:582-3; PMID:17460676; http://dx.doi.org/10.1038/ng0507-582.
8. Melo SA, Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett 2011; 585:2087-99; PMID:20708002; http://dx.doi.org/10.1016/j. febslet.2010.08.009.
9. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 2006; 20:2202-7; PMID:16882971; http://dx.doi.org/10.1101/ gad.1444406.
10. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40:43-50; PMID:18066065; http://dx.doi.org/10.1038/ng.2007.30.
11. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009; 41:365-70; PMID:19219043; http://dx.doi.org/10.1038/ ng.317.
12. Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, et al. DICER1 mutations in familial pleuropulmonaryblastoma. Science 2009; 325:965; PMID:19556464; http://dx.doi.org/10.1126/science.1174334.
13. Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 2010; 18:303-15; PMID:20951941; http://dx.doi.org/10.1016/j. ccr.2010.09.007.
14. Lopez-Serra P, Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 2011; 354:1-14; PMID:21860412.
15. Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS, et al. Ultraconserved elements in the human genome. Science 2004; 304:1321-5; PMID:15131266; http://dx.doi.org/10.1126/science.1098119.
16. Katzman S, Kern AD, Bejerano G, Fewell G, Fulton L, Wilson RK, et al. Human genome ultraconserved elements are ultraselected. Science 2007; 317:915; PMID:17702936; http://dx.doi.org/10.1126/science.1142430.
17. Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007; 12:215-29; PMID:17785203; http://dx.doi.org/10. 1016/j.ccr.2007.07.027.
18. Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, et al. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 2010; 29:6390-401; PMID:20802525; http://dx.doi.org/10.1038/onc.2010.361.
19. Gerbi SA. Small nucleolar RNA. Biochem Cell Biol 1995; 73:845-58; PMID:8722000; http://dx.doi.org/10.1139/o95-092.
20. Cavaillé J, Nicoloso M, Bachellerie JP. Targeted ribose methylation of RNA in vivo directed by tailored antisense RNA guides. Nature 1996; 383:732-5; PMID:8878486; http://dx.doi.org/10.1038/383732a0.
21. Kiss-László Z, Henry Y, Bachellerie JP, Caizergues-Ferrer M, Kiss T. Site-specific ribose methylation of preribosomal RNA: a novel function for small nucleolar RNAs. Cell 1996; 85:1077-88; PMID:8674114; http://dx.doi.org/10.1016/S0092-8674(00)81308-2.
22. Ganot P, Bortolin ML, Kiss T. Site-specific pseudouridine formation in preribosomal RNA is guided by small nucleolar RNAs. Cell 1997; 89:799-809; PMID:9182768; http://dx.doi.org/10.1016/S0092-8674(00)80263-9.
23. Li T, Zhou X, Wang X, Zhu D, Zhang Y. Identification and characterization of human snoRNA core promoters. Genomics 2010; 96:50-6; PMID:20353816; http://dx.doi.org/10.1016/j.ygeno.2010.03.010.
24. Lestrade L, Weber MJ. snoRNA-LBME-db, a comprehensive database of human H/ACA and C/D box snoRNAs. Nucleic Acids Res 2006; 34:158-62; PMID:16381836; http://dx.doi.org/10.1093/nar/gkj002.
25. Balakin AG, Smith L, Fournier MJ. The RNA world of the nucleolus: two major families of small RNAs defined by different box elements with related functions. Cell 1996; 86:823-34; PMID:8797828; http://dx.doi.org/10.1016/S0092- 8674(00)80156-7.
26. Bachellerie JP, Cavaillé J, Hüttenhofer A. The expanding snoRNA world. Biochimie 2002; 84:775-90; PMID:12457565; http://dx.doi.org/10. 1016/S0300-9084(02)01402-5.
27. Reichow SL, Hamma T, Ferré-D'Amaré AR, Varani G. The structure and function of small nucleolarribonucleoproteins. Nucleic Acids Res 2007; 35:1452-64; PMID:17284456; http://dx.doi.org/10.1093/nar/gkl1172.
28. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, et al. X-linked dyskeratosiscongenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19:32-8; PMID:9590285; http://dx.doi.org/10.1038/ng0598-32.
29. Walne AJ, Vulliamy T, Marrone A, Beswick R, Kirwan M, Masunari Y, et al. Genetic heterogeneity in autosomal recessive dyskeratosiscongenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet 2007; 16:1619-29; PMID:17507419; http://dx.doi.org/10.1093/hmg/ddm111.
30. Vulliamy T, Beswick R, Kirwan M, Marrone A, Digweed M, Walne A, et al. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosiscongenita. Proc Natl Acad Sci USA 2008; 105:8073-8; PMID:18523010; http://dx.doi.org/10.1073/pnas.0800042105.
31. Chang LS, Lin SY, Lieu AS, Wu TL. Differential expression of human 5S snoRNA genes. Biochem Biophys Res Commun 2002; 299:196-200; PMID:12437969; http://dx.doi.org/10.1016/S0006-291X(02)02623-2.
32. Mourtada-Maarabouni M, Hedge VL, Kirkham L, Farzaneh F, Williams GT. Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5). J Cell Sci 2008; 121:939-46; PMID:18354083; http://dx.doi.org/10.1242/jcs.024646.
33. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009; 28:195-208; PMID:18836484; http://dx.doi.org/10. 1038/onc.2008.373.
34. Dong XY, Guo P, Boyd J, Sun X, Li Q, Zhou W, et al. Implication of snoRNA U50 in human breast cancer. J Genet Genomics 2009; 36:447-54; PMID:19683667; http://dx.doi.org/10.1016/S1673-8527(08)60134-4.
35. Dong XY, Rodriguez C, Guo P, Sun X, Talbot JT, Zhou W, et al. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet 2008; 17:1031-42; PMID:18202102; http://dx.doi.org/10.1093/hmg/ddm375.
36. Horsthemke B, Wagstaff J. Mechanisms of imprinting of the Prader-Willi/Angelman region. Am J Med Genet A 2008; 146:2041-52; PMID:18627066; http://dx.doi.org/10.1002/ajmg.a.32364.
37. Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 2006; 311:230-2; PMID:16357227; http://dx.doi.org/10.1126/science.1118265.
38. Bratkovi T, Rogelj B. Biology and applications of small nucleolar RNAs. Cell Mol Life Sci 2011; 68:3843-51; PMID:21748470; http://dx.doi.org/10.1007/ s00018-011-0762-y.
39. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683-92; PMID:17320506; http://dx.doi.org/10.1016/j.cell.2007.01.029.
40. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17:330-9; PMID:21386836; http://dx.doi.org/ 10.1038/nm.2305.
41. Kiss T, Filipowicz W. Exonucleolytic processing of small nucleolar RNAs from pre-mRNA introns. Genes Dev 1995; 9:1411-24; PMID:7797080; http://dx.doi.org/10.1101/gad.9.11.1411.
42. Tycowski KT, Shu MD, Steitz JA. A mammalian gene with introns instead of exons generating stable RNA products. Nature 1996; 379:464-6; PMID:8559254; http://dx.doi.org/10.1038/379464a0.
43. Hoeppner MP, White S, Jeffares DC, Poole AM. Evolutionarily stable association of intronicsnoRNAs and microRNAs with their host genes. Genome Biol Evol 2009; 1:420-8; PMID:20333211; http://dx.doi.org/10.1093/gbe/evp045.
44. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002; 12:996-1006; PMID:12045153.
45. Takai D, Jones PA. The CpG island searcher: a new WWW resource. In Silico Biol 2003; 3:235-40; PMID:12954087.
46. Saini HK, Griffiths-Jones S, Enright AJ. Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci USA 2007; 104:17719-24; PMID:17965236; http://dx.doi.org/10.1073/pnas.0703890104.
47. Zhou X, Ruan J, Wang G, Zhang W. Characterization and identification of microRNA core promoters in four model species. PLoS Comput Biol 2007; 3:37; PMID:17352530; http://dx.doi.org/10.1371/journal.pcbi.0030037.
48. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002; 416:552-6; PMID:11932749; http://dx.doi.org/10.1038/416552a.
49. Sandoval J, Heyn HA, Moran S, Serra-Musach J, Pujana MA, Bibikova M, et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011; 6:692-702; PMID:21593595; http://dx.doi.org/10. 4161/epi.6.6.16196.
50. Yang JH, Zhang XC, Huang ZP, Zhou H, Huang MB, Zhang S, et al. snoSeeker: an advanced computational package for screening of guide and orphan snoRNA genes in the human genome. Nucleic Acids Res 2006; 34:5112-23; PMID:16990247; http://dx.doi.org/10.1093/nar/gkl672.
51. Kiss AM, Jády BE, Bertrand E, Kiss T. Human box H/ACA pseudouridylation guide RNA machinery. Mol Cell Biol 2004; 24:5797-807; PMID:15199136; http://dx.doi.org/10.1128/MCB.24.13.5797-807.2004.
52. Luo Y, Li S. Genome-wide analyses of retrogenes derived from the human box H/ACA snoRNAs. Nucleic Acids Res 2007; 35:559-71; PMID:17175533.
53. Weber MJ. Mammalian small nucleolar RNAs are mobile genetic elements. PLoS Genet 2006; 2:205; PMID:17154719; http://dx.doi.org/10.1371/journal.pgen. 0020205.
54. McMahon M, Ayllón V, Panov KI, O'Connor R. Ribosomal 18 S RNA processing by the IGF-Iresponsive WDR3 protein is integrated with p53 function in cancer cell proliferation. J Biol Chem 2010; 285:18309-18; PMID:20392698; http://dx.doi.org/10.1074/jbc.M110.108555.
55. Peng Q, Wu J, Zhang Y, Liu Y, Kong R, Hu L, et al. 1A6/DRIM, a novel t-UTP, activates RNA polymerase I transcription and promotes cell proliferation. PLoS One 2010; 5:14244; PMID:21151873; http://dx.doi.org/10.1371/journal.pone. 0014244.
56. Uemura M, Zheng Q, Koh CM, Nelson WG, Yegnasubramanian S, De Marzo AM. Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation. Oncogene 2011; 319:1-10; PMID:21822302.